XML 49 R26.htm IDEA: XBRL DOCUMENT
v3.8.0.1

EARNINGS/(LOSSES) PER SHARE | 12 Months Ended
--- | ---
Dec. 31, 2017
EARNINGS/(LOSSES) PER SHARE |
EARNINGS/(LOSSES) PER SHARE | 19. EARNINGS/(LOSSES) PER SHARE Basic earnings/(loss) per share and diluted earnings per share were calculated as follows:
|  | 2015 |  | 2016 |  | 2017 |
|  | RMB |  | RMB |  | RMB |
Numerator: |  |  |  |  |  |  |
Net income/(loss) attributable to Ctrip’s shareholders |  | 2,507,655,884 |  | (1,430,703,195 | ) | 2,142,011,537 |
Eliminate the dilutive effect of interest expense of convertible notes |  | 185,589,773 |  | — |  | 52,229,311 |
Numerator for diluted earnings/(loss) per share |  | 2,693,245,657 |  | (1,430,703,195 | ) | 2,194,240,848 |
Denominator: |  |  |  |  |  |  |
Denominator for basic earnings/(loss) per ordinary share |  |  |  |  |  |  |
- weighted average ordinary shares outstanding |  | 37,797,698 |  | 59,166,582 |  | 66,300,808 |
Dilutive effect of share options |  | 2,962,481 |  | — |  | 2,978,969 |
Dilutive effect of convertible notes |  | 6,102,417 |  | — |  | 2,345,083 |
Dilutive effect of convertible notes sold warrants |  | 512,652 |  | — |  | 151,033 |
Denominator for diluted earnings/(loss) per ordinary share |  | 47,375,248 |  | 59,166,582 |  | 71,775,893 |
Basic earnings/(loss) per ordinary share |  | 66.34 |  | (24.18 | ) | 32.31 |
Diluted earnings/(loss) per ordinary share |  | 56.85 |  | (24.18 | ) | 30.57 |
Basic earnings/(loss) per ADS |  | 8.29 |  | (3.02 | ) | 4.04 |
Diluted earnings/(loss) per ADS |  | 7.11 |  | (3.02 | ) | 3.82 |
The 2018, 2020, 2025 and 2022 Notes, the 2025 Priceline and Hillhouse Notes and 2022 Priceline Notes were not included in the computation of diluted EPS in 2017 because the inclusion of such instrument would be anti-dilutive. All the convertible senior notes had anti-dilutive impact and were excluded in the computation of diluted EPS in 2016, given the loss reported. The 2025 Notes and the 2025 Priceline and Hillhouse Notes were not included in the computation of diluted EPS in 2015 because the inclusion of such instrument would be anti-dilutive. For the years ended December 31, 2015, 2016 and 2017, the Company had securities which could potentially dilute basic earnings per share in the future, which were excluded from the computation of diluted earnings/(loss) per share as their effects would have been anti-dilutive. Such weighted average numbers of ordinary shares outstanding are as following:
|  | 2015 |  | 2016 |  | 2017 |
|  | RMB |  | RMB |  | RMB |
2017 Notes |  | — |  | 435,248 |  | — |
2018 Notes |  | — |  | 2,551,360 |  | 2,002,507 |
2020 Notes |  | — |  | 1,608,985 |  | 1,608,984 |
2025 Notes |  | 486,999 |  | 935,550 |  | 935,550 |
2022 Notes |  | — |  | 559,282 |  | 1,860,885 |
2019 Priceline Notes |  | — |  | 1,536,338 |  | — |
2020 Priceline Notes |  | — |  | 599,400 |  | — |
2025 Priceline and Hillhouse Notes |  | 100,046 |  | 1,825,838 |  | 1,825,838 |
2022 Priceline Notes |  | — |  | 14,341 |  | 47,715 |
Outstanding weighted average stock options |  | 64,074 |  | 3,678,030 |  | 99,695 |
Sold Warrants |  | 1,734,865 |  | 303,176 |  | — |
|  | 2,385,984 |  | 14,047,548 |  | 8,381,174 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration